These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7786281)

  • 1. [Elevation of 7-dehydrocholesterol concentrations in serum and liver and pericentral peroxisome proliferation in hepatocytes of rats after inhibition of cholesterol biosynthesis by BM 15,766].
    Weiss MC; Baumgart E; Fahimi HD; Pill H; Rebel W; Hartig F
    Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):66-9. PubMed ID: 7786281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
    Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
    Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Sex-dependent ultrastructural differences.
    Baumgart E; Stegmeier K; Schmidt FH; Fahimi HD
    Lab Invest; 1987 May; 56(5):554-64. PubMed ID: 3573722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
    Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
    J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis.
    Pill J; Stegmeier K; Schmidt FH
    Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):167-74. PubMed ID: 2352446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
    Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
    Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis.
    Pill J; Witte EC; Schmidt FH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):552-6. PubMed ID: 2392158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
    Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS
    Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cholesterol biosynthesis by BM 15.766.
    Aufenanger J; Pill J; Stegmeier K; Schmidt FH
    Horm Metab Res; 1985 Nov; 17(11):612-3. PubMed ID: 3841087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol biosynthesis inhibited by BM15.766 induces holoprosencephaly in the rat.
    Kolf-Clauw M; Chevy F; Siliart B; Wolf C; Mulliez N; Roux C
    Teratology; 1997 Sep; 56(3):188-200. PubMed ID: 9358606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome.
    Honda A; Tint GS; Salen G; Kelley RI; Honda M; Batta AK; Chen TS; Shefer S
    Am J Med Genet; 1997 Jan; 68(3):282-7. PubMed ID: 9024560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism.
    Cunniff C; Kratz LE; Moser A; Natowicz MR; Kelley RI
    Am J Med Genet; 1997 Jan; 68(3):263-9. PubMed ID: 9024557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked alteration of sterol metabolism and composition without compromising retinal development or function.
    Fliesler SJ; Richards MJ; Miller C; Peachey NS
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1792-801. PubMed ID: 10393050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol delta 7-reductase, on cholesterol biosynthesis in primary rat hepatocytes.
    Aufenanger J; Pill J; Schmidt FH; Stegmeier K
    Biochem Pharmacol; 1986 Mar; 35(6):911-6. PubMed ID: 3754141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.
    Xu L; Liu W; Sheflin LG; Fliesler SJ; Porter NA
    J Lipid Res; 2011 Oct; 52(10):1810-20. PubMed ID: 21817059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of BM 15.766 on serum lipids in rats.
    Pill J; Schmidt FH; Stegmeier K; Witte EC
    Horm Metab Res; 1985 Oct; 17(10):543-4. PubMed ID: 3840766
    [No Abstract]   [Full Text] [Related]  

  • 20. Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis.
    Genaro-Mattos TC; Tallman KA; Allen LB; Anderson A; Mirnics K; Korade Z; Porter NA
    Toxicol Appl Pharmacol; 2018 Jun; 349():21-28. PubMed ID: 29698737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.